Posted July 24, 2020
Under the guise of speedier drug approvals, Big Pharma profits get a boost while public health is endangered. Action Alert! Many cancer drugs that are approved by the FDA do not have much benefit to patients. This is because approval can be based on dubious measurements of secondary benefits, referred to as “surrogate endpoints.” The FDA, with the help of Congress, has all but relinquished its role as a watchdog agency and instead treats Big Pharma as its partner. Read more.